Acurx Pharmaceuticals, Inc.

ACXP

Acurx Pharmaceuticals, Inc.

ACXP

Insider Sentiment (TTM):

Last Purchase:2025-01-06Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:163,206Shares Outstanding:2,718,433Institutional Ownership Pct.:6.00%

Earnings Market Reaction:

Filing Date:2026-05-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Acurx Pharmaceuticals, Inc. (ACXP) — SEC Financial Statements & Analysis

Acurx Pharmaceuticals, Inc. (ACXP) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash	9	8	6	6	5	4	6	6	9	7	7	9
Accounts And Other Receivables Net Current	0	0	0	0	-	0	0	0	-	0	-	-
Prepaid Expense Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	-	-	-	6	5	-	6	-	-	-	7	9
Assets	10	8	6	-	-	4	-	7	9	8	-	-
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	3	2	2	3	2	3	3	3	3	3	3	3
Liabilities Current	3	2	2	3	2	3	3	3	3	3	3	3
Liabilities	3	2	2	3	2	3	3	3	3	3	3	3
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	84	81	77	75	72	68	67	65	64	58	52	51
Retained Earnings Accumulated Deficit	-77	-75	-74	-72	-69	-67	-65	-62	-58	-53	-48	-45
Stockholders Equity	7	5	4	4	2	1	3	3	6	5	4	6
Liabilities And Stockholders Equity	10	8	6	6	5	4	6	7	9	8	7	9
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	-	-	-	0.001	-	-	-	-	-	-
Preferred Stock Shares Authorized	10	10	-	-	-	10	-	-	-	-	-	-
Preferred Stock Shares Issued	0	0	-	-	-	0	-	-	-	-	-	-
Preferred Stock Shares Outstanding	0	0	-	-	-	0	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	250	250	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	3	2	2	1	22	1	17	16	16	14	13	13
Shares Outstanding	3	2	2	1	22	1	17	16	16	14	13	13

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-22.94%	-26.61%	-	-	-	-	-	-	-	-	-	-
2025	-12.15%	22.03%	-22.28%	-8.93%	1.56%	12.05%	-35.54%	-44.58%	-52.51%	-26.55%	-56.89%	-60.48%
2024	14.83%	-1.44%	0.96%	15.79%	1.05%	-3.16%	-59.46%	-51.89%	-60.49%	-25.16%	-23.89%	-26.64%
2023	-3.63%	-12.54%	-36.63%	1.48%	-17.72%	195.12%	14.29%	11.43%	-8.86%	-29.04%	-20.22%	-7.72%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	-	-	-	2.38	1.93	-	1.80	-	-	-	2.22	3.06
Quick Ratio	-	-	-	2.36	1.86	-	1.77	-	-	-	2.19	3.03
Working Capital	-	-	-	3.57M	2.31M	-	2.66M	-	-	-	3.93M	6.22M
Leverage & Debt
Debt to Equity	0.36	0.46	0.68	0.73	1.08	5.27	1.25	0.92	0.52	0.65	0.82	0.49
Debt Ratio	-	-	-	0.42	0.52	-	0.55	-	-	-	0.45	0.33
Efficiency & Turnover
Asset Turnover TTM	-	-	-	0.00	0.00	-	0.00	-	-	-	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-2.76	-2.66	-2.82	-2.80	-2.96	-3.49	-4.02	-4.23	-4.15	-3.83	-3.26	-3.60
Free Cash Flow Per Share TTM	-2.26	-2.26	-2.42	-2.29	-2.34	-2.57	-3.01	-3.09	-2.83	-2.58	-1.82	-1.97
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-36.85%	-43.51%	-44.21%	-40.23%	-26.03%	-3.26%	29.18%	27.22%	30.24%	20.55%	-1.62%	-6.30%
EPS Growth (1Y)	-6.90%	-23.85%	-29.81%	-33.78%	-28.61%	-8.99%	23.20%	17.56%	17.57%	2.90%	-15.67%	-7.93%
Valuation Metrics
P/E TTM	-1.35	-0.94	-1.52	-3.65	-2.63	-4.66	-9.46	-10.64	-11.81	-19.98	-9.20	-14.73
P/B	1.44	1.42	3.84	10.23	13.52	106.95	58.35	51.94	31.60	62.40	29.75	31.17
Market Cap	10.09M	7.46M	13.95M	36.49M	31.26M	65.78M	155.45M	178.03M	189.54M	291.19M	117.05M	193.77M
Enterprise Value	830.57K	-92.11K	8.04M	30.43M	26.62M	62.08M	149.69M	171.67M	180.62M	283.72M	109.99M	184.62M
Calculated Values
Free Cash Flow TTM	-6.14M	-6.79M	-7.85M	-8.16M	-9.37M	-10.38M	-12.33M	-12.23M	-10.93M	-9.80M	-7.10M	-7.19M
Net Debt	-9.25M	-7.56M	-5.91M	-6.06M	-4.64M	-3.71M	-5.76M	-6.36M	-8.92M	-7.47M	-7.05M	-9.15M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-01-06Purchase

Owner: Scodari, Joseph C

Title: -

Shares: 24,631

Price/Share: $1.02

Value: $25,123.62

Shares Owned: 27,708

Relationship: Director

Ownership: Direct

2025-01-06Purchase

Owner: Dean, Jack H

Title: -

Shares: 9,852

Price/Share: $1.02

Value: $10,049.04

Shares Owned: 21,776

Relationship: Director

Ownership: Direct

2025-01-06Purchase

Owner: Donohue, James J.

Title: -

Shares: 9,852

Price/Share: $1.02

Value: $10,049.04

Shares Owned: 22,352

Relationship: Director

Ownership: Direct

2025-01-06Purchase

Owner: Sailer, Carl

Title: -

Shares: 24,631

Price/Share: $1.02

Value: $25,123.62

Shares Owned: 137,183

Relationship: Director

Ownership: Direct

2025-01-06Purchase

Owner: Luci, David P

Title: President and CEO

Shares: 49,261

Price/Share: $1.02

Value: $50,246.22

Shares Owned: 1,097,458

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-01-06	Scodari, Joseph C	Director	-	Direct	Purchase	24,631	1.02	$25,123.62	27,708	4
2025-01-06	Dean, Jack H	Director	-	Direct	Purchase	9,852	1.02	$10,049.04	21,776	4
2025-01-06	Donohue, James J.	Director	-	Direct	Purchase	9,852	1.02	$10,049.04	22,352	4
2025-01-06	Sailer, Carl	Director	-	Direct	Purchase	24,631	1.02	$25,123.62	137,183	4
2025-01-06	Luci, David P	Director,Officer,TenPercentOwner	President and CEO	Direct	Purchase	49,261	1.02	$50,246.22	1,097,458	4
2025-01-06	Deluccia, Robert J	Director,TenPercentOwner	-	Direct	Purchase	49,261	1.02	$50,246.22	1,010,196	4
2022-07-27	Sailer, Carl	Director	-	Direct	Purchase	19,737	3.80	$75,000.60	92,815	4
2022-07-27	Luci, David P	Director,Officer,TenPercentOwner	President and CEO	Direct	Purchase	19,737	3.80	$75,000.60	1,028,460	4
2022-07-27	Deluccia, Robert J	Director,TenPercentOwner	-	Direct	Purchase	19,737	3.80	$75,000.60	1,051,198	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

6.00%

Inst. Shares: 163,206

Shares Outstanding: 2,718,433

2025-12-31

4.62%

Inst. Shares: 138,609

Shares Outstanding: 2,997,586

2025-09-30

1.72%

Inst. Shares: 55,793

Shares Outstanding: 3,251,610

2025-06-30

70.10%

Inst. Shares: 2,503,007

Shares Outstanding: 3,570,798

2025-03-31

86.14%

Inst. Shares: 3,452,442

Shares Outstanding: 4,007,728

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	163,206	2,718,433	6.00%
2025-12-31	138,609	2,997,586	4.62%
2025-09-30	55,793	3,251,610	1.72%
2025-06-30	2,503,007	3,570,798	70.10%
2025-03-31	3,452,442	4,007,728	86.14%
2024-12-31	1,365,378	4,040,840	33.79%
2024-09-30	1,228,173	4,090,870	30.02%
2024-06-30	1,174,245	3,956,165	29.68%
2024-03-31	1,212,783	3,868,127	31.35%
2023-12-31	1,090,157	3,801,472	28.68%
2023-09-30	854,913	3,901,538	21.91%
2023-06-30	1,466,264	3,655,944	40.11%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Acurx Pharmaceuticals, Inc. (ACXP) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.